<p>Pfizer’s upbeat first-quarter earnings Pfizer Inc (PFE) posted bumper results for the first quarter of 2022, helped by strong sales of its COVID-19 vaccine and antiviral tablet. Net income of the pharmaceutical giant climbed 61% to $7.8 billion. Adjusted earnings of $1.62 beat analysts’ estimates of $1.47, easing concerns of lowered vaccine demand as economies [&hellip;]<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --></p> . A Global Investing Platform helping investors from India & Middle East invest in US listed
We care about your data, and we'd love to use cookies to make your experience better.